Related references
Note: Only part of the references are listed.Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia
John A. Pulikkan et al.
BLOOD (2010)
The miR-34 family in cancer and apoptosis
H. Hermeking
CELL DEATH AND DIFFERENTIATION (2010)
Acute Myeloid Leukemia With Biallelic CEBPA Gene Mutations and Normal Karyotype Represents a Distinct Genetic Entity Associated With a Favorable Clinical Outcome
Annika Dufour et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Elevated PIN1 expression by C/EBPα-p30 blocks C/EBPα-induced granulocytic differentiation through c-Jun in AML
J. A. Pulikkan et al.
LEUKEMIA (2010)
EPIGENETICS AND GENETICS Leukaemogenesis: more than mutant genes
Jianjun Chen et al.
NATURE REVIEWS CANCER (2010)
miR-34a as part of the resistance network in chronic lymphocytic leukemia
Thorsten Zenz et al.
BLOOD (2009)
miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53
Francisco Navarro et al.
BLOOD (2009)
Hematopoietic Stem Cell Expansion Precedes the Generation of Committed Myeloid Leukemia-initiating Cells in C/EBPα Mutant AML
Oxana Bereshchenko et al.
CANCER CELL (2009)
Emerging roles of E2Fs in cancer: an exit from cell cycle control
Hui-Zi Chen et al.
NATURE REVIEWS CANCER (2009)
Modeling of C/EBP alpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells
Peggy Kirstetter et al.
CANCER CELL (2008)
Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer
Dmitri Lodygin et al.
CELL CYCLE (2008)
Prognostic Significance of, and Gene and MicroRNA Expression Signatures Associated With, CEBPA Mutations in Cytogenetically Normal Acute Myeloid Leukemia With High-Risk Molecular Features: A Cancer and Leukemia Group B Study
Guido Marcucci et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Regulation of progenitor cell proliferation and granulocyte function by microRNA-223
Jonathan B. Johnnidis et al.
NATURE (2008)
A microRNA DNA methylation signature for human cancer metastasis
Amaia Lujambio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Transcriptional dysregulation during myeloid transformation in AML
T. Pabst et al.
ONCOGENE (2007)
Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis
Rene Opavsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells
Hiroshi Tazawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Tsung-Cheng Chang et al.
MOLECULAR CELL (2007)
Transcription factors in myeloid development: balancing differentiation with transformation
Frank Rosenbauer et al.
NATURE REVIEWS IMMUNOLOGY (2007)
AML patients with CEBPα mutations mostly retain identical mutant patterns but frequently change in allelic distribution at relapse:: a comparative analysis on paired diagnosis and relapse samples
LY Shih et al.
LEUKEMIA (2006)
Oncomirs - microRNAs with a role in cancer
A Esquela-Kerscher et al.
NATURE REVIEWS CANCER (2006)
E2F3a stimulates proliferation, p53-independent apoptosis and carcinogenesis in a transgenic mouse model
QX Paulson et al.
CELL CYCLE (2006)
BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas
K Nowak et al.
NUCLEIC ACIDS RESEARCH (2006)
A minicircuitry comprised of MicroRNA-223 and transcription factors NFI-A and C/EBPα regulates human granulopoiesis
F Fazi et al.
CELL (2005)
Loss of C/EBPα cell cycle control increases myeloid progenitor proliferation and transforms the neutrophil granulocyte lineage
BT Porse et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Leukaemia stem cells and the evolution of cancer-stem-cell research
BJP Huntly et al.
NATURE REVIEWS CANCER (2005)
CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics:: Prognostic relevance and analysis of cooperating mutations
S Fröhling et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBPα.
P Zhang et al.
IMMUNITY (2004)
Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1
A Iwama et al.
IMMUNITY (2004)
Expression and regulation of NFAT (nuclear factors of activated T cells) in human CD34+ cells:: down-regulation upon myeloid differentiation
A Kiani et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
The amino terminal and E2F interaction domains are critical for C/EBPα-mediated induction of granulopoietic development of hematopoietic cells
F D'Alo et al.
BLOOD (2003)
Disruption of differentiation in human cancer: AML shows the way
DG Tenen
NATURE REVIEWS CANCER (2003)
Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPα gene
H Asou et al.
GENES CHROMOSOMES & CANCER (2003)
Evidence for allelic evolution of C/EBPalpha mutations in acute myeloid leukaemia
J Tiesmeier et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases
C Schoch et al.
LEUKEMIA (2002)
E2F repression by C/EBPα is required for adipogenesis and granulopoiesis in vivo
BT Porse et al.
CELL (2001)
C-Myc is a critical target for C/EBPα in granulopoiesis
LM Johansen et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
C/EBPα inhibits cell growth via direct repression of E2F-DP-mediated transcription
BA Slomiany et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)